$45.57
1.89%
NYSE, Jan 02, 10:00 pm CET
ISIN
US4333131039
Symbol
HNGE

Hinge Health Target price 2026 - Analyst rating & recommendation

Hinge Health Classifications & Recommendation:

Buy
90%
Hold
10%

Hinge Health Price Target

Target Price $66.30
Price $45.56
Potential
Number of Estimates 16
16 Analysts have issued a price target Hinge Health 2027 . The average Hinge Health target price is $66.30. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 19 Analysts recommend Hinge Health to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Hinge Health stock has an average upside potential 2027 of . Most analysts recommend the Hinge Health stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2031

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 390.40 585.31
33.37% 49.93%
EBITDA Margin -4.73% 19.73%
88.90% 516.81%
Net Margin -3.06% 11.68%
91.73% 482.22%

17 Analysts have issued a sales forecast Hinge Health 2025 . The average Hinge Health sales estimate is

$585m
Unlock
. This is
27.52% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$609m 24.57%
Unlock
, the lowest is
$562m 30.46%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $390m 33.37%
2025
$585m 49.93%
Unlock
2026
$712m 21.59%
Unlock
2027
$829m 16.50%
Unlock
2028
$1.0b 24.23%
Unlock
2029
$1.2b 15.63%
Unlock
2030
$1.4b 14.02%
Unlock
2031
$1.5b 12.44%
Unlock

13 Analysts have issued an Hinge Health EBITDA forecast 2025. The average Hinge Health EBITDA estimate is

$116m
Unlock
. This is
119.34% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$156m 126.05%
Unlock
, the lowest is
$88.5m 114.82%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-18.5m 85.20%
2025
$116m 725.05%
Unlock
2026
$151m 31.13%
Unlock
2027
$196m 29.25%
Unlock
2028
$272m 38.84%
Unlock
2029
$317m 16.70%
Unlock
2030
$365m 15.08%
Unlock
2031
$414m 13.47%
Unlock

EBITDA Margin

2024 -4.73% 88.90%
2025
19.73% 516.81%
Unlock
2026
21.28% 7.86%
Unlock
2027
23.61% 10.95%
Unlock
2028
26.39% 11.77%
Unlock
2029
26.63% 0.91%
Unlock
2030
26.88% 0.94%
Unlock
2031
27.13% 0.93%
Unlock

17 Hinge Health Analysts have issued a net profit forecast 2025. The average Hinge Health net profit estimate is

$68.3m
Unlock
. This is
110.10% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$188m 127.74%
Unlock
, the lowest is
$-580m 14.24%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-11.9m 88.97%
2025
$68.3m 672.84%
Unlock
2026
$123m 80.38%
Unlock
2027
$148m 19.85%
Unlock
2028
$206m 39.13%
Unlock
2029
$234m 13.68%
Unlock
2030
$263m 12.37%
Unlock
2031
$291m 10.71%
Unlock

Net Margin

2024 -3.06% 91.73%
2025
11.68% 482.22%
Unlock
2026
17.32% 48.29%
Unlock
2027
17.82% 2.89%
Unlock
2028
19.96% 12.01%
Unlock
2029
19.62% 1.70%
Unlock
2030
19.33% 1.48%
Unlock
2031
19.04% 1.50%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.15 0.87
89.21% 680.00%
P/E 52.48
EV/Sales 5.31

17 Analysts have issued a Hinge Health forecast for earnings per share. The average Hinge Health EPS is

$0.87
Unlock
. This is
110.15% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$2.38 127.77%
Unlock
, the lowest is
$-7.37 14.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.15 89.21%
2025
$0.87 680.00%
Unlock
2026
$1.57 80.46%
Unlock
2027
$1.88 19.75%
Unlock
2028
$2.61 38.83%
Unlock
2029
$2.97 13.79%
Unlock
2030
$3.34 12.46%
Unlock
2031
$3.69 10.48%
Unlock

P/E ratio

Current
2025
52.48 1,087.17%
Unlock
2026
29.10 44.55%
Unlock
2027
24.28 16.56%
Unlock
2028
17.45 28.13%
Unlock
2029
15.35 12.03%
Unlock
2030
13.66 11.01%
Unlock
2031
12.34 9.66%
Unlock

Based on analysts' sales estimates for 2025, the Hinge Health stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.85
2025
5.31 37.85%
Unlock
2026
4.37 17.75%
Unlock
2027
3.75 14.16%
Unlock
2028
3.02 19.50%
Unlock
2029
2.61 13.52%
Unlock
2030
2.29 12.30%
Unlock
2031
2.03 11.07%
Unlock

P/S ratio

Current
2025
6.13 37.97%
Unlock
2026
5.04 17.75%
Unlock
2027
4.33 14.16%
Unlock
2028
3.48 19.51%
Unlock
2029
3.01 13.52%
Unlock
2030
2.64 12.30%
Unlock
2031
2.35 11.07%
Unlock

Current Hinge Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity
Locked
Locked
Locked Nov 05 2025
Barclays
Locked
Locked
Locked Nov 05 2025
Piper Sandler
Locked
Locked
Locked Nov 05 2025
Evercore ISI Group
Locked
Locked
Locked Oct 08 2025
Morgan Stanley
Locked
Locked
Locked Sep 23 2025
Stifel
Locked
Locked
Locked Sep 11 2025
Baird
Locked
Locked
Locked Sep 05 2025
Analyst Rating Date
Locked
Canaccord Genuity:
Locked
Locked
Nov 05 2025
Locked
Barclays:
Locked
Locked
Nov 05 2025
Locked
Piper Sandler:
Locked
Locked
Nov 05 2025
Locked
Evercore ISI Group:
Locked
Locked
Oct 08 2025
Locked
Morgan Stanley:
Locked
Locked
Sep 23 2025
Locked
Stifel:
Locked
Locked
Sep 11 2025
Locked
Baird:
Locked
Locked
Sep 05 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today